Michael Singer
Director at Cartesian Therapeutics, Inc. (RNAC) since November 2023
Michael Singer has filed 10 insider reports with the SEC since November 2023, as director at Cartesian Therapeutics, Inc. (RNAC). The latest filing, on March 13, 2026, reports gift at Cartesian Therapeutics, Inc. (RNAC).
- Filings
- 10
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Michael Singer is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince November 2023 | 49,578 | $6.14 | Mar 13, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 13, 2026RNACDirector Singer Michael gifted 6,555 units of Common Stock, decreasing direct ownership by 12% to 49,578 unitsForm 4Gift
- Jan 2, 2026RNACDirector Singer Michael was granted 2,600 units of Common Stock, increasing direct ownership by 5% to 56,133 unitsForm 4Grant or award
- Nov 18, 2025RNACDirector Singer Michael gifted 20,000 units of Common Stock, decreasing direct ownership by 27% to 53,533 unitsForm 4Gift
- Jan 2, 2025RNACDirector Singer Michael was granted 2,600 units of Common Stock, increasing direct ownership by 4% to 73,533 unitsForm 4Grant or award
- Dec 26, 2024RNACDirector Singer Michael gifted 20,000 units of Common Stock, decreasing direct ownership by 22% to 70,933 unitsForm 4Gift
- Nov 19, 2024RNACDirector Singer Michael gifted 28,821 units of Common Stock, decreasing direct ownership by 24% to 90,933 unitsForm 4Gift
- Apr 8, 2024RNACSinger Michael converted options into 753,781 units of Common Stock, increasing direct ownership by 1,147% to 119,754 unitsForm 4Exercise or conversion of a derivative
- Jan 2, 2024RNACSinger Michael was granted 178,000 units of Common Stock, increasing direct ownership by 162% to 288,123 unitsForm 4Grant or awardGift
- Nov 13, 2023RNACSinger Michael was granted 110,123 shares and acquired 337,271 sharesForm 4Grant or awardOther acquisition or disposition
- Nov 13, 2023RNACMichael Singer became an insiderForm 3New insider
Compare Michael Singer with
- Michael Singer vs Elizabeth Hoge1 shared
- Michael Singer vs Murat Kalayoglu1 shared
- Michael Singer vs Carsten Brunn1 shared
- Michael Singer vs Blaine Davis1 shared
- Michael Singer vs Milos Miljkovic1 shared
- Michael Singer vs Nishan M DeSilva1 shared
Other insiders at the same companies
- Elizabeth HogeRNAC
- Murat KalayogluRNAC
- Carsten BrunnRNAC
- Milos MiljkovicRNAC
- Blaine DavisRNAC
- Nishan M DeSilvaRNAC
- Kemal MalikRNAC
- Patrick J ZennerRNAC
- June Ann SeymourRNAC
- Timothy C BarabeRNAC
- Emily EnglishRNAC
- Timothy A SpringerRNAC
- Adrian Ion BotRNAC
- Christopher M JewellRNAC
- Metin KurtogluRNAC
- Carrie Smith CoxRNAC
Questions about Michael Singer
- What is Michael Singer's role at Cartesian Therapeutics, Inc.?
- Michael Singer reports to the SEC as director at Cartesian Therapeutics, Inc. (RNAC), according to the latest filing on March 13, 2026.
- How many shares does Michael Singer own?
- After the latest filing that states it, Michael Singer directly owned 49,578 shares of Cartesian Therapeutics, Inc. (RNAC). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Singer bought or sold stock recently?
- No open-market purchases or sales by Michael Singer are on file. The filings report gift, grant or award, exercise or conversion of a derivative and other acquisition or disposition.
- How do I get alerts when Michael Singer files?
- Follow Michael Singer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Singer (SEC CIK 0002000122). Totals count each trade once, skipping amendments whose original is on file, from Nov 15, 2023 on. View on SEC EDGAR · Get this as JSON